Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus.
Guo LX, Liu GE, Chen L, Wang HF, Guo J, Zheng XL, Duan BH, Wang DZ, Zhu W, Wang K, Tan WS, Chen Q, Li QZ, Yang J, Zhang Q, Xie PF, Lei MX. Guo LX, et al. Among authors: guo j. Front Endocrinol (Lausanne). 2021 Sep 30;12:712200. doi: 10.3389/fendo.2021.712200. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34659110 Free PMC article. Clinical Trial.
Standards of care for type 2 diabetes in China.
Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, Zhu D, Chen L, Chen L, Guo L, Guo X, Ji Q, Li Q, Li X, Liu J, Ran X, Shan Z, Shi L, Song G, Yang L, Yang Y, Yang W; Chinese Diabetes Society. Weng J, et al. Diabetes Metab Res Rev. 2016 Jul;32(5):442-58. doi: 10.1002/dmrr.2827. Diabetes Metab Res Rev. 2016. PMID: 27464265 Free PMC article. No abstract available.
Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial.
Chen Y, Liu X, Li Q, Ma J, Lv X, Guo L, Wang C, Shi Y, Li Y, Johnsson E, Wang M, Zhao J, Ji L. Chen Y, et al. Diabetes Obes Metab. 2018 Apr;20(4):1044-1049. doi: 10.1111/dom.13161. Epub 2017 Dec 18. Diabetes Obes Metab. 2018. PMID: 29144061 Clinical Trial.
A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study.
Guo L, Chen L, Chang B, Yang L, Liu Y, Feng B. Guo L, et al. Diabetes Obes Metab. 2018 Dec;20(12):2740-2747. doi: 10.1111/dom.13454. Epub 2018 Aug 2. Diabetes Obes Metab. 2018. PMID: 29961975 Clinical Trial.
Chinese clinical guidelines for continuous glucose monitoring (2018 edition).
Bao Y, Chen L, Chen L, Dou J, Gao Z, Gao L, Guo L, Guo X, Ji L, Ji Q, Jia W, Kuang H, Li Q, Li Q, Li X, Li Y, Li L, Liu J, Ma J, Ran X, Shi L, Song G, Wang Y, Weng J, Xiao X, Xie Y, Xi G, Yang L, Zhao Z, Zhou J, Zhou Z, Zhu D, Zou D; Chinese Diabetes Society. Bao Y, et al. Diabetes Metab Res Rev. 2019 Sep;35(6):e3152. doi: 10.1002/dmrr.3152. Epub 2019 Apr 25. Diabetes Metab Res Rev. 2019. PMID: 30884108 Review.
Standards of medical care for type 2 diabetes in China 2019.
Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, Zou D, Guo L, Ji Q, Chen L, Chen L, Dou J, Guo X, Kuang H, Li L, Li Q, Li X, Liu J, Ran X, Shi L, Song G, Xiao X, Yang L, Zhao Z; Chinese Diabetes Society. Jia W, et al. Diabetes Metab Res Rev. 2019 Sep;35(6):e3158. doi: 10.1002/dmrr.3158. Epub 2019 May 29. Diabetes Metab Res Rev. 2019. PMID: 30908791 Review.
Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).
Ji L, Chen L, Wang Y, Ma Z, Ran X, Sun Z, Xu X, Wang G, Guo L, Shan Z. Ji L, et al. Adv Ther. 2019 Jun;36(6):1485-1496. doi: 10.1007/s12325-019-00951-4. Epub 2019 Apr 19. Adv Ther. 2019. PMID: 31004325 Clinical Trial.
319 results